04:58 PM EST, 12/18/2024 (MT Newswires) -- Sanjiv Patel, Director, President and CEO, on December 16, 2024, sold 100,000 shares in Relay Therapeutics ( RLAY ) for $500,000. Following the Form 4 filing with the SEC, Patel has control over a total of 2,028,033 shares of the company, with 766,130 shares held directly and 1,261,903 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1812364/000095017024137960/xslF345X05/ownership.xml